Literature DB >> 2826658

Cleavage site between VP1 and P2A of human rhinovirus is different in serotypes 2 and 14.

H Kowalski1, I Maurer-Fogy, M Zorn, H Mischak, E Kuechler, D Blaas.   

Abstract

The viral capsid protein VP1 of human rhinovirus serotype 2 (HRV2) was cleaved with cyanogen bromide. The peptides thus obtained were separated on an HPLC butyl reversed phase column. Their positions on VP1 were determined by amino-terminal sequencing using the known nucleotide sequence of the genomic RNA of HRV2. The putative carboxy-terminal peptide was further cleaved with trypsin and the resulting fragments were separated on a C18 reversed phase column. Amino-terminus of sequencing of the C-terminal peptide revealed alanine as being the carboxy terminus of VP1 in HRV2. This indicates that the processing of the polyprotein is different in HRV2 from the processing previously reported for HRV14 and poliovirus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2826658     DOI: 10.1099/0022-1317-68-12-3197

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  2 in total

1.  Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors.

Authors:  A Molla; C U Hellen; E Wimmer
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

2.  Identification and characterization of a 3C-like protease from rabbit hemorrhagic disease virus, a calicivirus.

Authors:  B Boniotti; C Wirblich; M Sibilia; G Meyers; H J Thiel; C Rossi
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.